Clinical Trials on Hyperlipoproteinemia Type I
Total 57367 results
-
University of Texas Southwestern Medical CenterRecruitingType 1 HyperlipoprotenemiaUnited States
-
S.LAB (SOLOWAYS)Center of New Medical Technologies; Triangel ScientificCompletedLDL Hyperlipoproteinemia | Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia | Triglyceride Storage Type I or II DiseaseRussian Federation
-
UniQure Biopharma B.V.CompletedLipoprotein Lipase Deficiency | Familial Hyperlipoproteinemia Type 1 | Familial HyperchylomicronemiaGermany
-
University of Texas Southwestern Medical CenterCompletedHypertriglyceridemia | Hyperlipoproteinemia Type IUnited States
-
Amsterdam Molecular TherapeuticsICON plcTerminatedHyperlipoproteinemia Type ICanada
-
University of Texas Southwestern Medical CenterTerminatedType 1 HyperlipoproteinemiaUnited States
-
Catabasis PharmaceuticalsCompletedHypertriglyceridemia | Hyperlipoproteinemia Type I | Lipoprotein Lipase Deficiency, Familial | Chylomicronemia, FamilialCanada
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1United States, Canada, Germany, Israel, Italy, South Africa, Spain, United Kingdom, Brazil, France, Netherlands
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1Canada
-
Nina HermansUniversity Hospital, AntwerpRecruitingLow-Density-Lipoprotein-Type [LDL] HyperlipoproteinemiaBelgium
-
Technische Universität DresdenKaneka Pharma Europe N.V.RecruitingLipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaGermany
-
AstraZenecaCompletedHypertriglyceridemia | Hyperlipidemia | Hyperlipoproteinemia Type V | Hyperlipoproteinemia Type IV | Hyperlipoproteinemia Type IIbMexico
-
Hospices Civils de LyonCompleted
-
Changi General HospitalNot yet recruitingCardiovascular Diseases | Hypercholesterolemia | Lipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaSingapore
-
University of Colorado, DenverCompletedLipoprotein Lipase Deficiency
-
LipimetiX Development, LLCCompletedHypercholesterolemia | Hyperlipoproteinemia Type IIAustralia
-
UniQure Biopharma B.V.Chiesi Farmaceutici S.p.A.Withdrawn
-
Fresenius Medical Care Deutschland GmbHCompletedHypercholesterolemia, Familial | LIPOPROTEIN TYPES--Lp SYSTEM Lp(a) HYPERLIPOPROTEINEMIAGermany
-
Novartis PharmaceuticalsRecruitingHyperlipoproteinemia (a)Germany
-
Novartis PharmaceuticalsActive, not recruiting
-
Université de SherbrookeInstitut de Recherches Cliniques de MontrealRecruitingLipoprotein Lipase DeficiencyCanada
-
Novartis PharmaceuticalsTerminatedFamilial Chylomicronemia Syndrome (FCS) (HLP Type I)South Africa, Germany, United Kingdom, France, United States, Canada, Netherlands
-
CENTOGENE GmbH RostockWithdrawnLipoprotein Lipase Deficiency | Inborn Error of Lipid Metabolism | Corneal ArcusGermany, India, Sri Lanka
-
Saint-Joseph UniversityUnknownDyslipidemias | LDL HyperlipoproteinemiaLebanon
-
Amsterdam Molecular TherapeuticsThe Clinical Trial CompanyCompletedFamilial Lipoprotein Lipase DeficiencyCanada
-
Amsterdam Molecular TherapeuticsInternational Antiviral Therapy Evaluation CenterUnknownFamilial Lipoprotein Lipase DeficiencyCanada
-
Amsterdam Molecular TherapeuticsThe Clinical Trial CompanyUnknown
-
Arrowhead PharmaceuticalsActive, not recruitingFamilial ChylomicronemiaKorea, Republic of, Canada, Australia, Singapore, Belgium, Spain, Japan, United States, Austria, Germany, Ireland, Oman, Poland, Israel, New Zealand, Argentina, France, Croatia, Mexico, Serbia, Turkey
-
Akcea TherapeuticsCaligorRx, Inc.No longer availableFamilial Chylomicronemia
-
Arrowhead PharmaceuticalsCompletedHypertriglyceridemia | Familial ChylomicronemiaAustralia, Canada, New Zealand
-
Atlantic Health SystemRegeneron PharmaceuticalsNot yet recruitingFamilial Hypercholesterolemia | High Density Lipoprotein Deficiency | Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia | Apolipoprotein B 100, Familial Defective | Low-Density-Lipoid-Type HyperlipoproteinemiaUnited States
-
Hospices Civils de LyonCompletedHyperlipoproteinemia
-
Nordic Pharma, USANutrasource Pharmaceutical and Nutraceutical Services, Inc.Withdrawn
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedFamilial Chylomicronemia SyndromeUnited States, Israel, Spain, Italy, United Kingdom, Netherlands, Canada, Hungary, Sweden, France, Norway, Portugal, Slovakia
-
Ionis Pharmaceuticals, Inc.Active, not recruitingFamilial Chylomicronemia SyndromeUnited States, Canada, Sweden
-
AstraZenecaCompleted
-
PfizerCompletedHypertriglyceridemia | Hyperlipoproteinemia Type IVUnited States, Canada
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | HyperlipoproteinemiaUnited States
-
Merck Sharp & Dohme LLCCompletedHyperlipoproteinemia Type II | Hypercholesterolemia, Familial
-
Visirna Therapeutics HK LimitedNot yet recruitingFamilial Chylomicronemia Syndrome
-
Ionis Pharmaceuticals, Inc.Active, not recruitingFamilial Chylomicronemia SyndromeSpain, United Kingdom, France, Canada, United States, Italy, Netherlands, Norway, Portugal, Slovakia, Sweden
-
Ionis Pharmaceuticals, Inc.AvailableFamilial Chylomicronemia Syndrome
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedFamilial Chylomicronemia SyndromeUnited States, Brazil, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, South Africa, Spain, United Kingdom
-
Zhejiang UniversityUnknownHyperlipoproteinemiaChina
-
Organon and CoMerck Sharp & Dohme LLCCompletedAtherosclerosis | Hypercholesterolemia | Hyperlipoproteinemia Type II
-
PfizerTIMI Study GroupCompletedDyslipidemias | Hyperlipidemias | HyperlipoproteinemiasUnited States, Canada, Poland
-
PfizerTerminatedHyperlipoproteinemia Type IIICanada, United States
-
Merck Sharp & Dohme LLCTerminatedHyperlipoproteinemia Type II | Homozygous Familial Hypercholesterolemia
-
Eli Lilly and CompanyActive, not recruitingMetabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | HyperlipoproteinemiaUnited States, Mexico, Poland, Canada, Turkey, Japan, Argentina
-
Zhejiang UniversityCompletedHyperlipoproteinemiaChina